✦ LIBER ✦

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

✍ Scribed by E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green

Book ID: 117291137
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 258 KB
Volume: 365
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)71142-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK2 V617F tyrosine kinase mutation in c

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders

✍ Quentmeier, H; MacLeod, R A F; Zaborski, M; Drexler, H G 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 276 KB

Epigenetic alterations complement mutati

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders

✍ Jost, E; do Ó, N; Dahl, E; Maintz, C E; Jousten, P; Habets, L; Wilop, S; Herman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

The JAK2 V617F activating tyrosine kinas

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

✍ Steensma, David P. (author);Dewald, Gordon W. (author);Lasho, Terra L. (author); 📂 Article 📅 2005 🏛 American Society of Hematology 🌐 English ⚖ 116 KB

The JAK2 V617F activating tyrosine kinas

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

✍ Steensma, David P. (author);Dewald, Gordon W. (author);Lasho, Terra L. (author); 📂 Article 📅 2005 🏛 American Society of Hematology 🌐 English ⚖ 116 KB

A Gain-of-Function Mutation of JAK2 in M

A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

✍ Kralovics, Robert; Passamonti, Francesco; Buser, Andreas S.; Teo, Soon-Siong; Ti 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 521 KB

A Gain-of-Function Mutation of JAK2 in M

A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

✍ Kralovics, Robert; Passamonti, Francesco; Buser, Andreas S.; Teo, Soon-Siong; Ti 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 521 KB

## background Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors